Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2004

View Archived Issues

Efficacy of stampidine shown in vitro against resistant HIV-1 isolates

Antiinflammatory action of ethyl pyruvate mediated in part via GSH depletion

Good safety profile reported for BBR-3576 in patients with advanced solid tumors

Full clinical results reported for eculizumab in paroxysmal nocturnal hemoglobinuria

2003 record year at Serono

New Viracept formulation recommended for approval in Europe

Iseganan program selected for CMA Pilot 2 program

Medtronic receives conditional approval to commence ENDEAVOR III trial

University of Pennsylvania studies chromium picolinate for metabolic syndrome

Vivus to develop Testosterone MDTS, Estradiol MDTS for U.S.

Salix updates Q4 and year-end 2003 developments

Seattle Genetics highlights 2003 development progress

Two series of factor VIIa inhibitors presented by BMS researchers

Novel renin inhibitors in early development at Actelion

Spanish researchers describe new muscarinic M3 antagonists and their use

Novel oxytocin antagonists and their use as tocolytics reported by ARS team

Indian scientists claim new anthramycin-based antitumor agents

Allergan patent covers antitumor agents for breast and prostate cancer therapy

New COX inhibitors identified by Boehringer Ingelheim scientists

Two novel series of antibacterial agents prepared and tested at GSK

Elan completes recovery plan

Erbitux receives FDA approval

Aventis selects target in GPC Biotech osteoarthritis alliance

FDA approval for benazepril hydrochloride

Prevnar allocation program continues

Concerta approved in Australia

Symbollon plans pivotal IoGen trial for fibrocystic breast disease

Altana seeks European approval for Daxas

Dermatrends demonstrates effective transdermal delivery of testosterone

Neurologix completes merger with Change Technology Partners

E-5564 reported safe and effective in a human model of clinical sepsis

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...